Biocon gains on posting 36% growth in Biologics segment in Q1FY19

27 Jul 2018 Evaluate

Biocon is currently trading at Rs. 609.20, up by 50.10 points or 8.96% from its previous closing of Rs. 559.10 on the BSE.

The scrip opened at Rs. 571.40 and has touched a high and low of Rs. 614.00 and Rs. 570.75 respectively. So far 633457 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 695.00 on 05-Jun-2018 and a 52 week low of Rs. 318.85 on 17-Aug-2017.

Last one week high and low of the scrip stood at Rs. 586.30 and Rs. 543.80 respectively. The current market cap of the company is Rs. 36630.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 21.15% and 18.18% respectively.

Biocon has recorded a strong growth of 36% at Rs 250 crore in the Biologics segment in Q1FY19 which comprises of Novel Biologics and Biosimilars. The growth was largely driven by higher sales of biosimilar monoclonal antibodies (mAbs) in emerging markets, supported by Insulins business.

During the quarter, the company’s insulins portfolio gained market share in several emerging markets such as Malaysia, Algeria and UAE. The company’s brand Insugen, now holds a 75% share of the rh-insulin market in Malaysia.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

377.55 -1.50 (-0.40%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×